AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17768289 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral Gradient Acoustic Reflectometry (SGAR)
Number of subjects: 786
Study 17768289 — intervention group
Group type: COMPARATOR
Intervention: Tympanometry
Number of subjects: 786
Study 15067791 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking 3 days/week at 65% of target heart rate reserve
Number of subjects: 0
Study 15067791 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking 5 days/week at 65% of target heart rate reserve
Number of subjects: 0
Study 12825328 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (Ex, n = 18) underwent simple, progressive lower body resistance exercises, 3 times/week for 10 weeks
Number of subjects: 25
Study 12825328 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (Ex, n = 18)
Number of subjects: 25
Study 12825328 — intervention group
Group type: COMPARATOR
Intervention: Control group (Con, n = 7) maintained usual daily activities
Number of subjects: 25
Study 10479220 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of vegetables and fruits
Number of subjects: 0
Study 10479220 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of vegetables and fruits
Number of subjects: 0
Study 10479220 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental dietary studies in humans
Number of subjects: 0
Study 10479220 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-arm trials, randomized crossover studies
Number of subjects: 0
Study 10479220 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose to years of treatment
Number of subjects: 0
Study 10479220 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary control methods
Number of subjects: 0
Study 7741542 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 micrograms/g) applied twice daily for up to 12 weeks
Number of subjects: 67
Study 7741542 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 micrograms/g)
Number of subjects: 67
Study 7741542 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle of calcipotriol ointment)
Number of subjects: 67
Study 2202789 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative fluorouracil (5‐FU) and heparin administered via the portal vein
Number of subjects: 1158
Study 2202789 — intervention group
Group type: COMPARATOR
Intervention: No further treatment following curative resection
Number of subjects: 1158
Study 7275458 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 kcal VLCD (17 g protein)
Number of subjects: 25
Study 7275458 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 kcal VLCD (40 g protein)
Number of subjects: 25
Study 7275458 — intervention group
Group type: EXPERIMENTAL
Intervention: 80/180 kcal VLCD (80 kcal for 1st and 2nd week, 180 kcal for 3rd and 4th week)
Number of subjects: 25
Study 7275458 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed VLCD (80 kcal for 1st and 2nd week, 180 kcal with 17 g protein + 25.5 g CHO for 3rd and 4th week)
Number of subjects: 25
Study 11850494 — intervention group
Group type: EXPERIMENTAL
Intervention: 90Y‐ibritumomab tiuxetan
Number of subjects: 0
Study 29439395 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic-mixture (Vivomixx®, Visbiome®, DeSimone Formulation®)
Number of subjects: 53
Study 28010833 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervi Pantotrichum Cornu pharmacopuncture
Number of subjects: 40
Study 28010833 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehmannia glutinosa pharmacopuncture
Number of subjects: 40
Study 23911209 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative regional cerebral oxygen saturation (rSO2) monitoring with active display and Murkin treatment intervention protocol
Number of subjects: 40
Study 23911209 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study 23911209 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventional group (rSO2 monitoring)
Number of subjects: 40
Study 22093485 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary therapy (dietary advice six times during pregnancy)
Number of subjects: 54
Study 22093485 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary therapy
Number of subjects: 54
Study 22093485 — intervention group
Group type: COMPARATOR
Intervention: Close follow-up group (control)
Number of subjects: 54
Study 19934619 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated parathyroid hormone (PTH) > or = 62 ng/L (IV-quartile)
Number of subjects: 514
Study 18662417 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized nursing intervention addressing psychological and physical care post-surgery
Number of subjects: 145
Study 15673874 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 40 mg IM and IV lidocaine 3 mg . kg(‐1) . h(‐1) (group DM+L)
Number of subjects: 100
Study 15673874 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (DM) 40 mg IM (group DM)
Number of subjects: 100
Study 15673874 — intervention group
Group type: EXPERIMENTAL
Intervention: IV lidocaine 3 mg . kg(‐1) . h(‐1) (group L)
Number of subjects: 100
Study 15673874 — intervention group
Group type: COMPARATOR
Intervention: Chlorpheniramine maleate (CPM) 20 mg IM and IV normal saline (N/S) (group C)
Number of subjects: 100
Study 12771835 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard design with a fixed polyethylene bearing
Number of subjects: 22
Study 12771835 — intervention group
Group type: EXPERIMENTAL
Intervention: Design with a mobile bearing
Number of subjects: 22
Study 12771835 — intervention group
Group type: EXPERIMENTAL
Intervention: New design with a spherical medial femoral condyle with a fixed bearing
Number of subjects: 22
Study 12771835 — intervention group
Group type: COMPARATOR
Intervention: Meniscal design (not explicitly named as control)
Number of subjects: 22
Study 11800105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) using infrared diode laser (GaAlAs) 830 nm continuous wave and HeNe 632.8 nm combined with diode laser 904‐nm pulsed wave
Number of subjects: 74
Study 11800105 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 74
Study 11800105 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated patients)
Number of subjects: 74
Study 8649560 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE) combined with azathioprine 2 mg/kg, performed once a week for 4 weeks and thereafter every second week for 20 weeks (14 treatments)
Number of subjects: 11
Study 8649560 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange (PE) combined with azathioprine 2 mg/kg
Number of subjects: 11
Study 8649560 — intervention group
Group type: COMPARATOR
Intervention: Control period (no plasma exchange)
Number of subjects: 11
Study 1500744 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymerase chain reaction (PCR)
Number of subjects: 0
Study 1500744 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV cocultivation
Number of subjects: 0
Study 1500744 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma p24 antigen
Number of subjects: 0
Study 6512000 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 0
Study 30878174 — intervention group
Group type: EXPERIMENTAL
Intervention: Curvilinear supine position
Number of subjects: 104
Study 30878174 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard positioning)
Number of subjects: 104
Study 30178484 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Tactile Object Recognition Test (fTORT)
Number of subjects: 28
Study 30178484 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=10)
Number of subjects: 28
Study 30178484 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (n=6)
Number of subjects: 28
Study 27372844 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (n=33)
Number of subjects: 100
Study 27372844 — intervention group
Group type: EXPERIMENTAL
Intervention: MHF-tPCS (n=30)
Number of subjects: 100
Study 27372844 — intervention group
Group type: COMPARATOR
Intervention: sham-tDCS (n=37)
Number of subjects: 100
Study 27372844 — intervention group
Group type: EXPERIMENTAL
Intervention: MHF-tPCS
Number of subjects: 100
Study 27372844 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 100
Study 27372844 — intervention group
Group type: COMPARATOR
Intervention: sham-tDCS
Number of subjects: 100
Study 25241756 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga training (YT)
Number of subjects: 309
Study 25241756 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise (PE)
Number of subjects: 309
Study 25241756 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 309
Study 22526196 — intervention group
Group type: EXPERIMENTAL
Intervention: QUIXIL® fibrin sealant (2 ml)
Number of subjects: 24
Study 22526196 — intervention group
Group type: COMPARATOR
Intervention: Control (no QUIXIL®)
Number of subjects: 24
Study 20488759 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron
Number of subjects: 179
Study 20488759 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 179
Study 20488759 — intervention group
Group type: EXPERIMENTAL
Intervention: metoclopramide
Number of subjects: 179
Study 18926128 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 99
Study 18926128 — intervention group
Group type: COMPARATOR
Intervention: 2003 American Diabetes Association recommended diet
Number of subjects: 99
Study 15827700 — intervention group
Group type: EXPERIMENTAL
Intervention: Finite Element Method
Number of subjects: 12
Study 15827700 — intervention group
Group type: COMPARATOR
Intervention: Dentofacial Planner Plus
Number of subjects: 12
Study 12585188 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium wilfordii polyglycoside (TWP)
Number of subjects: 100
Study 12585188 — intervention group
Group type: COMPARATOR
Intervention: Bimolani (control)
Number of subjects: 100
Study 10512206 — intervention group
Group type: COMPARATOR
Intervention: Hypoxia (F(I)O2 0.155)
Number of subjects: 6
Study 10512206 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (F(I)O2 0.209)
Number of subjects: 6
Study 10512206 — intervention group
Group type: COMPARATOR
Intervention: Hyperoxia (F(I)O2 0.293)
Number of subjects: 6
Study 7577284 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 22
Study 7577284 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 22
Study 8150760 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime 1 g bd
Number of subjects: 131
Study 8150760 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime 1 g tds
Number of subjects: 131
Study 3529375 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly low-dose methotrexate (Mtx)
Number of subjects: 0
Study 3529375 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31502272 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (parenteral plus enteral; total 400 mg/kg/d)
Number of subjects: 60
Study 31502272 — intervention group
Group type: COMPARATOR
Intervention: Isonitrogenous control
Number of subjects: 60
Study 29287668 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of Integrated Posttraumatic Stress and Substance Use (TIPSS)
Number of subjects: 0
Study 29287668 — intervention group
Group type: COMPARATOR
Intervention: Standard cognitive-behavioral treatment (CBT) for SUD
Number of subjects: 0
Study 28459509 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Traditional Chinese Diet (BCTD)
Number of subjects: 284
Study 28459509 — intervention group
Group type: COMPARATOR
Intervention: Western Standard Diet (WSD)
Number of subjects: 284
Study 26341920 — intervention group
Group type: EXPERIMENTAL
Intervention: Panitumumab plus FOLFIRI
Number of subjects: 0
Study 26341920 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 0
Study 23731573 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (6000 mg iv one hour before contrast CT)
Number of subjects: 120
Study 23731573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 23731573 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 120
Study 21439551 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group intervention
Number of subjects: 253
Study 21439551 — intervention group
Group type: COMPARATOR
Intervention: Bibliotherapy
Number of subjects: 253
Study 21439551 — intervention group
Group type: COMPARATOR
Intervention: Educational brochure control
Number of subjects: 253
Study 20071890 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational program for caregivers
Number of subjects: 38
Study 20071890 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 38
Study 16983477 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior 90 degrees partial fundoplication
Number of subjects: 112
Study 16983477 — intervention group
Group type: COMPARATOR
Intervention: Nissen fundoplication
Number of subjects: 112
Study 15274868 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiometer's Pico 70
Number of subjects: 160
Study 15274868 — intervention group
Group type: EXPERIMENTAL
Intervention: SIMS-Portex's Pro‐Vent
Number of subjects: 160
Study 15274868 — intervention group
Group type: COMPARATOR
Intervention: Becton Dickinson's Preset
Number of subjects: 160
Study 15274868 — intervention group
Group type: COMPARATOR
Intervention: SIMS-Concord's Pulsator
Number of subjects: 160
Study 15274868 — intervention group
Group type: COMPARATOR
Intervention: Marquest's Quick ABG
Number of subjects: 160
Study 15274868 — intervention group
Group type: COMPARATOR
Intervention: Delay of 30 minutes
Number of subjects: 160
Study 15274868 — intervention group
Group type: COMPARATOR
Intervention: Delay of 60 minutes
Number of subjects: 160
Study 11546967 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtracheal open ventilation (TOV)
Number of subjects: 11
Study 11546967 — intervention group
Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV) at 10 cm H2O
Number of subjects: 11
Study 11546967 — intervention group
Group type: COMPARATOR
Intervention: Open minitracheotomy
Number of subjects: 11
Study 11546967 — intervention group
Group type: COMPARATOR
Intervention: Transtracheal gas insufflation
Number of subjects: 11
Study 9697781 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (n = 1524)
Number of subjects: 3040
Study 9697781 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 1516)
Number of subjects: 3040
Study 7970508 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (160 mg/day)
Number of subjects: 2000
Study 7970508 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 2000
Study 7970508 — intervention group
Group type: COMPARATOR
Intervention: Other hormonal treatments
Number of subjects: 2000
Study 3276136 — intervention group
Group type: EXPERIMENTAL
Intervention: Lebanese meal (sandwich with unleavened bread and hummos)
Number of subjects: 8
Study 3276136 — intervention group
Group type: EXPERIMENTAL
Intervention: Greek meal (lentil stew)
Number of subjects: 8
Study 3276136 — intervention group
Group type: EXPERIMENTAL
Intervention: All meals (Indian, Italian, Chinese, Greek, Western, Lebanese)
Number of subjects: 8
Study 30063618 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 60
Study 30063618 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 60
Study 26603917 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir-ritonavir
Number of subjects: 1236
Study 26603917 — intervention group
Group type: COMPARATOR
Intervention: lamivudine
Number of subjects: 1236
Study 24036842 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus followed by a 2 mg/kg/h infusion until the end of the surgical procedure)
Number of subjects: 51
Study 24036842 — intervention group
Group type: COMPARATOR
Intervention: Saline (same volume as lidocaine)
Number of subjects: 51
Study 22800410 — intervention group
Group type: EXPERIMENTAL
Intervention: STarT Back Tool
Number of subjects: 300
Study 22800410 — intervention group
Group type: COMPARATOR
Intervention: Reference standard questionnaires (disability, catastrophizing, fear, and depression)
Number of subjects: 300
Study 20857058 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g/day of soy
Number of subjects: 60
Study 20857058 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day of n‐3 fatty acids (fish oil)
Number of subjects: 60
Study 20857058 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day of n‐3 fatty acids (fish oil) and 25 g/day of soy
Number of subjects: 60
Study 20857058 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained usual diet)
Number of subjects: 60
Study 18424064 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 892
Study 18424064 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 892
Study 15968233 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily atomoxetine
Number of subjects: 153
Study 15968233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 15968233 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 153
Study 12855253 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 15
Study 12855253 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 15
Study 12855253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 9785713 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 22
Study 9785713 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 22
Study 2709169 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty development course in teaching medical interviewing
Number of subjects: 49
Study 1264546 — intervention group
Group type: EXPERIMENTAL
Intervention: Daylight phototherapy for 96 hours
Number of subjects: 57
Study 1264546 — intervention group
Group type: COMPARATOR
Intervention: No phototherapy (control)
Number of subjects: 57
Study 29906601 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF (400 mg once daily) + DCV (60 mg once daily)
Number of subjects: 125
Study 29906601 — intervention group
Group type: COMPARATOR
Intervention: SOF (400 mg once daily) + SMV (150 mg once daily)
Number of subjects: 125
Study 26883129 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual supervisor training module
Number of subjects: 81
Study 26883129 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 81
Study 25700752 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1(7-36) amide at 1.2 pmol/kg/min
Number of subjects: 20
Study 25700752 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 23338569 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated ventilation (AV)
Number of subjects: 60
Study 23338569 — intervention group
Group type: COMPARATOR
Intervention: Protocolized ventilation (PV)
Number of subjects: 60
Study 21324330 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa flavanols (720mg CF)
Number of subjects: 30
Study 21324330 — intervention group
Group type: COMPARATOR
Intervention: White chocolate (control)
Number of subjects: 30
Study 19171828 — intervention group
Group type: EXPERIMENTAL
Intervention: Explorative saccade training (EST) for 6 weeks (digit-search task)
Number of subjects: 28
Study 19171828 — intervention group
Group type: COMPARATOR
Intervention: Flicker-stimulation training (FT) for 6 weeks (blind-hemifield stimulation by flickering letters)
Number of subjects: 28
Study 17709063 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-standardised acupuncture (12 sessions, at least 6 local and 2 distant points needled per affected knee)
Number of subjects: 294
Study 17709063 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal acupuncture (12 sessions, superficial needling of at least 8 of 10 predefined, bilateral, distant non-acupuncture points)
Number of subjects: 294
Study 17709063 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (2 months no acupuncture)
Number of subjects: 294
Study 15459835 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalation of 800 microg salbutamol
Number of subjects: 16
Study 15459835 — intervention group
Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 16
Study 11742431 — intervention group
Group type: EXPERIMENTAL
Intervention: Saquinavir-enhancing therapy (SQV) with stavudine (d4T) and one of ritonavir, nelfinavir, or delavirdine.
Number of subjects: 31
Study 11742431 — intervention group
Group type: COMPARATOR
Intervention: Control group (ZDV-associated mutations).
Number of subjects: 31
Study 9682180 — intervention group
Group type: EXPERIMENTAL
Intervention: 36h continuous sleep deprivation (SD)
Number of subjects: 20
Study 9682180 — intervention group
Group type: COMPARATOR
Intervention: nil sleep deprivation (control)
Number of subjects: 20
Study 7989960 — intervention group
Group type: EXPERIMENTAL
Intervention: HPMC strips containing 40% doxycycline, applied twice a week for 6 weeks
Number of subjects: 11
Study 7989960 — intervention group
Group type: EXPERIMENTAL
Intervention: MC strips containing 40% doxycycline, applied twice a week for 6 weeks
Number of subjects: 11
Study 7989960 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement (root-planing only)
Number of subjects: 11
Study 3260659 — intervention group
Group type: EXPERIMENTAL
Intervention: Early coronary bypass surgery
Number of subjects: 767
Study 3260659 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 767
Study 159714 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline hydrochloride
Number of subjects: 48
Study 159714 — intervention group
Group type: COMPARATOR
Intervention: Zinc sulphate/citrate complex
Number of subjects: 48
Study 30056612 — intervention group
Group type: EXPERIMENTAL
Intervention: US-TAPb
Number of subjects: 100
Study 30056612 — intervention group
Group type: COMPARATOR
Intervention: Control (no TAPb)
Number of subjects: 100
Study 28107598 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving initial abstinence (measured by negative urine screens)
Number of subjects: 440
Study 28107598 — intervention group
Group type: EXPERIMENTAL
Intervention: Retention in trials (measured by days retained)
Number of subjects: 440